CLINICAL TRIAL SERVICES AGREEMENT AMENDMENT NO. 5 TO WORK STATEMENT NB-1Trial Services Agreement • May 20th, 2014 • Radius Health, Inc. • Blank checks
Pursuant to Section 2.3, 2.11 and 11.7 of the Agreement, the parties wish to enter into this Amendment No. 5 to Work Statement NB-1 (“Amendment No. 5”) effective as of May 19, 2014 (“Amendment Date”). Capitalized terms used in this Amendment No. 5 and not defined herein are used with the meanings ascribed to them in the Agreement and Work Statement NB-1.
CLINICAL TRIAL SERVICES AGREEMENT AMENDMENT NO. 4 TO WORK STATEMENT NB-1Trial Services Agreement • April 1st, 2014 • Radius Health, Inc. • Blank checks
Pursuant to Section 2.3, 2.11 and 11.7 of the Agreement, the parties wish to enter into this Amendment No. 4 to Work Statement NB-1 (“Amendment No. 4”) effective as of March 28, 2014 (“Amendment Date”). Capitalized terms used in this Amendment No. 4 and not defined herein are used with the meanings ascribed to them in the Agreement and Work Statement NB-1.
CLINICAL TRIAL SERVICES AGREEMENT AMENDMENT NO. 5 TO WORK STATEMENT NB-3Trial Services Agreement • February 25th, 2016 • Radius Health, Inc. • Pharmaceutical preparations
Pursuant to Section 2.3, 2.11 and 11.7 of the Agreement, the parties wish to enter into this Amendment No. 5 to Work Statement NB-3 (“Amendment No. 5”) effective as of January 15, 2016 (“Amendment Date”). Capitalized terms used in this Amendment No. 5 and not defined herein are used with the meanings ascribed to them in the Agreement and Work Statement NB-3.
CLINICAL TRIAL SERVICES AGREEMENT AMENDMENT NO. 8 TO WORK STATEMENT NB-1Trial Services Agreement • February 25th, 2016 • Radius Health, Inc. • Pharmaceutical preparations
Pursuant to Section 2.3, 2.11 and 11.7 of the Agreement, the parties wish to enter into this Amendment No. 8 to Work Statement NB-1 (“Amendment No. 8”) effective as of August 15, 2014 (“Amendment Date”). Capitalized terms used in this Amendment No. 8 and not defined herein are used with the meanings ascribed to them in the Agreement and Work Statement NB-1.
CLINICAL TRIAL SERVICES AGREEMENT AMENDMENT NO. 2 TO WORK STATEMENT NB-3Trial Services Agreement • May 6th, 2015 • Radius Health, Inc. • Pharmaceutical preparations
Pursuant to Section 2.3, 2.11 and 11.7 of the Agreement, the parties wish to enter into this Amendment No. 2 to Work Statement NB-3 (“Amendment No. 2”) effective as of March 23, 2015 (“Amendment Date”). Capitalized terms used in this Amendment No. 2 and not defined herein are used with the meanings ascribed to them in the Agreement and Work Statement NB-3.
ContractTrial Services Agreement • July 22nd, 2015
CLINICAL TRIAL SERVICES AGREEMENT AMENDMENT NO. 4 TO WORK STATEMENT NB-3Trial Services Agreement • February 25th, 2016 • Radius Health, Inc. • Pharmaceutical preparations
Pursuant to Section 2.3, 2.11 and 11.7 of the Agreement, the parties wish to enter into this Amendment No. 4 to Work Statement NB-3 (“Amendment No. 4”) effective as of October 21, 2015 (“Amendment Date”). Capitalized terms used in this Amendment No. 4 and not defined herein are used with the meanings ascribed to them in the Agreement and Work Statement NB-3.
CLINICAL TRIAL SERVICES AGREEMENT AMENDMENT NO. 6 TO WORK STATEMENT NB-1Trial Services Agreement • August 12th, 2014 • Radius Health, Inc. • Blank checks
Pursuant to Section 2.3, 2.11 and 11.7 of the Agreement, the parties wish to enter into this Amendment No. 6 to Work Statement NB-1 (“Amendment No. 6”) effective as of July 22, 2014 (“Amendment Date”). Capitalized terms used in this Amendment No. 6 and not defined herein are used with the meanings ascribed to them in the Agreement and Work Statement NB-1.
ContractTrial Services Agreement • May 5th, 2020 • Massachusetts
EX-10.1 2 q1100194_ex10-1.htm CLINICAL TRIAL SERVICES AGREEMENT This Agreement is effective October 4, 2011 (“Effective Date”) by and between: Harvard Clinical Research Institute, Inc. (“HCRI”) 930 Commonwealth Avenue Boston, Massachusetts 02215 and InspireMDLtd. (“InspireMD”) 3 Menorat Hamor St. Tel Aviv, Israel “MGuard Stent System Clinical Trial in Patients with Acute Myocardial Infarction” 1 WHEREAS, InspireMD (“Sponsor”) desires to engage HCRI for the purpose of providing Clinical Trial Services, as defined in Exhibit A to this Agreement, which will serve as the Scope of Work and budget for the Agreement, for the protocol for the “MGuard Stent System Clinical Trial in Patients with Acute Myocardial Infarction” Study, which shall be developed by HCRI under a separate consulting agreement, with such Protocol being incorporated by reference; and WHEREAS, HCRI and its professionals have experience in the development and administration of clinical trials of various Investigational Prod
CLINICAL TRIAL SERVICES AGREEMENTTrial Services Agreement • October 2nd, 2012 • Advaxis, Inc. • Pharmaceutical preparations • Pennsylvania
This Clinical Trial Services Agreement (“Agreement”) is between Advaxis, Inc. (“Sponsor”) , a for-profit corporation organized under the laws of Delaware, USA and holder of IND Number 13712, and the Gynecologic Oncology Group (“GOG”) , a not-for-profit corporation organized under the laws of the District of Columbia, to conduct the Clinical Trial according to the Protocol attached as Exhibit A and incorporated by reference in this Agreement. The Principal Investigator for the GOG shall be Philip J. DiSaia, M.D. The Clinical Trial will be directed by Warner K. Huh, M.D. (“Study Chair”), according to the Protocol.
CLINICAL TRIAL SERVICES AGREEMENT AMENDMENT NO. 7 TO WORK STATEMENT NB-1Trial Services Agreement • August 12th, 2014 • Radius Health, Inc. • Blank checks
Pursuant to Section 2.3, 2.11 and 11.7 of the Agreement, the parties wish to enter into this Amendment No. 7 to Work Statement NB-1 (“Amendment No. 7”) effective as of July 22, 2014 (“Amendment Date”). Capitalized terms used in this Amendment No. 7 and not defined herein are used with the meanings ascribed to them in the Agreement and Work Statement NB-1.
WITNESSETH:Trial Services Agreement • August 14th, 1997 • Kendle International Inc • Services-commercial physical & biological research • Illinois
CLINICAL TRIAL SERVICES AGREEMENT AMENDMENT NO. 3 TO WORK STATEMENT NB-1Trial Services Agreement • November 14th, 2013 • Radius Health, Inc. • Blank checks
Pursuant to Section 2.3, 2.11 and 11.7 of the Agreement, the parties wish to enter into this Amendment No. 3 to Work Statement NB-1 (“Amendment No. 3”) effective as of November 6, 2013 (“Amendment Date”). Capitalized terms used in this Amendment No. 3 and not defined herein are used with the meanings ascribed to them in the Agreement and Work Statement NB-1.
Qrator Free Trial Services AgreementTrial Services Agreement • March 21st, 2024
This Free Trial Services Agreement (“Agreement”) is between Qrator Labs CZ s.r.o. and its Affiliates (as defined below) (also referred to as “Qrator”, “we,” “us,” or “our”) and the Entity (as defined below) you represent, or if you do not designate an entity in connection with your subscription or use of the Services (as defined below), you individually (“you” or “your”) and governs your use of our Services (as defined below).
SERVICES AGREEMENTTrial Services Agreement • October 27th, 2017
